Substance active (DCI)
- nifédipine
- lidocaïne chlorhydrate
Informations techniques
Exploitant
LABORATOIRES LEURQUIN MEDIOLANUM SAS
Présentation
NIFEXINE,0,3 g/1,50 g, crème rectale
1 tube(s) aluminium de 30 g avec canule endorectale en polyéthylène basse densité (PEBD) (CIP : 34009 302 010 1 5)
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
LeemuLez1G9PYmWs
Français